SPRY1 and breast cancer: SPRY1 was reported to be associated with many kinds of tumors, such as breast cancer (He et al., 2016), colorectal cancer (Zhang et al., 2016), and human epithelial ovarian cancer (Masoumi‐Moghaddam, Amini, Wei, Robertson, & Morris, 2015).